Pioneering mRNA technology - Moderna
Messenger RNA (mRNA) already exists in your body. It carries a “message” - instructions that direct your cells what to do. mRNA medicines fight diseases in a different way than traditional …
Moderna - Wikipedia
Moderna, Inc. (/ m ə ˈ d ɜːr n ə / mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA …
Our Story - Moderna
We’re making biotech history. Since 2010, we have worked to build the industry's leading mRNA technology platform. Learn more about Moderna’s history.
How Moderna is Building a Digital Biotech
Mar 2, 2020 · At Moderna, building a digital biotech is a foundational component of who we are and is a key enabler of our mission to create a new class of mRNA medicines for patients. …
Moderna and BioNTech – who are they? - pharmaphorum
Jan 8, 2025 · Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. Just who are these companies and …
The MIT scientists behind the Moderna vaccine
Feb 23, 2021 · The origins of both the Moderna and Pfizer vaccines can be found in the early days of biotech—before Kendall Square was known as “the most innovative square mile on …
Moderna Announces Its Global Public Health Strategy
Mar 7, 2022 · Moderna announces commitment to advance vaccines targeting 15 pathogens identified as biggest public health risk by WHO and CEPI into clinical studies by 2025.
We got an exclusive look inside Moderna's labs, where the biotech ...
Jul 12, 2021 · The $90 billion biotech is making a fortune from its COVID-19 vaccine. But its rich valuation has also led to a fierce debate about Moderna's future.
This mysterious $2 billion biotech is revealing the secrets ... - AAAS
Feb 1, 2017 · Moderna aims to design messenger RNA (mRNA) that directs cells to make a protein that works as a drug or vaccine. To succeed, the mRNA has to enter the cell, avoid …
Moderna's mRNA Technology Looks Undervalued Despite Lower …
3 days ago · Moderna's massive covid vaccine sales and prepayments left it with $18.2 billion in cash at the end of 2022, but that balance is steadily shrinking due to previous share …
- Some results have been removed